Skip to content

13F-HR filed by JGP Global Gestao de Recursos Ltda.

JGP Global Gestao de Recursos Ltda. filed this 13F-HR for the quarter ended 2017-12-31, filed 2018-02-01, with 19 holding rows worth $204,765,000.

Accession
0001536562-18-000002
Filed
2018-02-01
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2017

A holdings report, 20 entries on the cover page, a total value of $204,765,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $204,765,000 with VALUE read as thousands by filing date, 13F file number 028-16384. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
KRAFT HEINZ CO COM500754106Stock1,062,458$82,617,000thousands by filing date
BANCO MACRO S A05961W105SPON ADR B263,881$30,579,000thousands by filing date
META PLATFORMS INC CL A30303M102COM155,000$27,351,000thousands by filing date
ISHARES INC MSCI BRAZIL ETF464286400MSCI BRAZIL ETF95,800$25,725,000thousands by filing date
LOMA NEGRA C I A S A MTN 1454150E104SPONSORED ADS936,176$21,569,000thousands by filing date
SPY78462F103SHS75,000$3,034,000thousands by filing date
ARCELORMITTAL SA LUXEMBOURG NY REGISTRY SH03938L203ADR69,549$2,247,000thousands by filing date
INCYTE CORP COM45337C102Stock22,208$2,103,000thousands by filing date
NUCOR CORP COM670346105Stock26,499$1,685,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM16,977$1,514,000thousands by filing date
ITAU UNIBANCO HLDG S A SPON ADR REP PFD465562106ADR100,000$1,300,000thousands by filing date
SEATTLE GENETICS INC812578102COM20,603$1,102,000thousands by filing date
POSCO HOLDINGS INC SPONSORED ADR693483109ADR10,000$781,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM12,516$748,000thousands by filing date
EXELIXIS INC COM30161Q104Stock20,020$609,000thousands by filing date
ASSEMBLY BIOSCIENCES INC045396108COM13,196$597,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM34,149$491,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM12,273$370,000thousands by filing date
Boston Scientific Corporation101137107COM13,834$343,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001536562-18-000002this filing2018-02-01acceptance time not in the bulk data set